Trius Therapeutics, Inc. (NASDAQ:TSRX)
| CAPS Rating |
|
|---|
TSRX
VS S&P 500 (SPY)
TSRX News and Commentary
- U.S. Biofirms Progress Offshore with Diverse Deals – Blogs @ The Motley Fool
- NASDAQ Changes Up Biotech Index Members & Weightings – 247wallst
- Trius Offering Of 8.6 Million Shares Prices At 9.3% Discount – SmartMoney
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Trius To Offer Shares, Says SEC Requested Info About 3Q Revenue – SmartMoney
- Trius Therapeutics Predicted to Rise on Rival to Pfizer Antibiotic – Minyanville
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
How do you think TSRX will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
59
Outperform
3
Underperform
All-Star Players
12
Outperform
0
Underperform
Wall Street
5
Outperform
0
Underperform
RSS Headlines
Fool UK
